Host Hotels & Resorts enters the final days of May riding a six-week re-rating that has outpaced most of its peers — and the Street is still revising higher even as the stock nudges above several freshly-raised price targets.
The rally tells the clearest story. HST closed at $23.11 on Tuesday, up 6.1% on the week and 10.6% over the past month. That strong month compares favourably with close peers: XHR gained 5.9% on the week, RHP 5.6%, and PK — among the most sensitive names in the group — led with 8.2%. The sector move has a macro tailwind rather than an idiosyncratic HST catalyst, but the company's Q1 numbers helped, with RevPAR growth above sector averages and management projecting pricing power in premium markets. The next earnings event is not until 29 July.
Analyst targets have been climbing in step. The pattern over the past two months is unusual: almost every firm in coverage has raised its target, and not one has cut a rating. Truist lifted its target to $24 on Tuesday, keeping a Buy. Citigroup moved to $24 in mid-May. Morgan Stanley went to $22. The consensus mean price target now sits at roughly $22.93 — fractionally below the current $23.11, meaning the stock has just traded through the average Street target. That is worth watching: further upgrades would need meaningful positive revisions to stay relevant to price action from here. The one dissenter in tone, if not in action, is Morgan Stanley, which remains at Equal-Weight even after two consecutive target lifts from $18 to $22.
The positioning picture is unremarkable for a REIT this size. Short interest sits at 4.4% of the free float — moderate, not aggressive. Over the past month, it has drifted slightly lower, down around 0.8%. Borrow costs are cheap, running just under 0.55% annually, up about 11% on the week but still well within normal territory. Availability in the lending pool is extremely loose — available shares represent roughly 6,484% of the current short position, meaning there is no scarcity at all for anyone wanting to establish or add to a short. The ORTEX short score of 38 places HST firmly in the lower half of the short-conviction distribution. Nothing in the lending market suggests bears are building a meaningful campaign here.
Options are the one angle that introduces a note of caution. The put/call ratio is running at 3.01, elevated versus its 20-day average of 2.01 and close to the 52-week high of 3.38. The z-score of 0.94 is sub-threshold — not extreme — but the sustained week-long cluster of readings above 3.0 is notable. Put open interest has been heavy relative to calls since mid-May, contrasting with a more balanced book through April and early May. Whether this reflects hedges against a stock that has moved 10% in a month, or genuine caution ahead of the Q3 reporting cycle, the options market is incrementally more defensive than the price action alone would imply.
On the ownership side, the register is dominated by passive and REIT-specialist capital. BlackRock holds 11.3% of shares, Vanguard and its affiliates combined approach 15%, and Cohen & Steers — a specialist REIT allocator — has a 7.9% stake that has been unchanged. Insider activity leans modestly negative in tone: the CIO sold $1.3 million worth in early May at $22, and the broader 90-day net across all officers shows about $9.5 million in net disposals. None of the sales carry high significance scores and several occurred close to scheduled programme dates, but there has been no offsetting buying from management — worth keeping in mind as the stock moves above the range where many of those sales were executed.
The setup heading into summer is one where price has run ahead of consensus targets, options traders are quietly hedging, and short sellers are uninspired. What to watch from here is whether revised targets follow the stock above $23, or whether the earnings-to-price ratio at July's Q2 print needs to clear a new bar to keep the re-rating alive.
See the live data behind this article on ORTEX.
Open HST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
